A matching-adjusted indirect comparison of asciminib versus ponatinib, nilotinib and dasatinib in chronic phase chronic myeloid leukemia patients after ≥2 tyrosine kinase inhibitors Meeting Abstract
| Authors: | Atallah, E. L.; Maheshwari, V.; Mauro, M. J.; Boquimpani, C.; Rea, D.; Hochhaus, A.; Minami, Y.; Saini, L.; Corbin, R. |
| Abstract Title: | A matching-adjusted indirect comparison of asciminib versus ponatinib, nilotinib and dasatinib in chronic phase chronic myeloid leukemia patients after ≥2 tyrosine kinase inhibitors |
| Meeting Title: | ISPOR 2022: The Future of HEOR in Patient-Driven Digital Healthcare Systems |
| Journal Title: | Value in Health |
| Volume: | 25 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2022 May 15-18 |
| Meeting Location: | Washington, DC |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2022-07-01 |
| Start Page: | S521 |
| Language: | English |
| ACCESSION: | WOS:000828757301461 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jval.2022.04.1226 |
| Notes: | Meeting Abstract: MSR19 -- Hybrid meeting, also available online -- Source: Wos |
